New treatment Xadago to help 100,000 Canadians living with Parkinson’s

News

Author: Parkinson's Life editorsPublished: 5 May 2017

Parkinson's LifePrep: Parkinson's LifeCook: Parkinson's LifeServes:

News image

More than 100,000 Canadians living with Parkinson’s will benefit from a new product to be launched in the country.

The drug known as ‘Xadago’, currently readily available in several countries across Europe, helps control motor symptoms and complications over a 24-month period.

Xadago will be the first new oral treatment for Parkinson’s in almost 15 years in Canada. On 21 March 2017 the Food and Drug Administration in the US approved the use of Xadago for the treatment of Parkinson’s as an add-on therapy to levodopa/carbidopa.

Go Back

Share this story

Comments


Related articles


Interviews

“We made our own bit of history”

Completing the ‘world's hardest triathlon’ for Parkinson’s disease

READ MORE
arol da Barra - Salvador - Bahia – Brasil

In my country

Could physical therapy be the future of specialised Parkinson’s care in Brazil?

Filling the physical therapy gaps in Brazil's healthcare system

READ MORE
Happy middle aged couple piggybacking on the beach

Health & Fitness

Sex and young onset Parkinson’s

Coping with the impact of Parkinson’s on sexuality at a younger age

READ MORE